123 related articles for article (PubMed ID: 35793396)
21. Cytotoxicity of cinchona alkaloid organocatalysts against MES-SA and MES-SA/Dx5 multidrug-resistant uterine sarcoma cell lines.
Pósa SP; Dargó G; Nagy S; Kisszékelyi P; Garádi Z; Hámori L; Szakács G; Kupai J; Tóth S
Bioorg Med Chem; 2022 Aug; 67():116855. PubMed ID: 35640378
[TBL] [Abstract][Full Text] [Related]
22. Circumvention of resistance to photodynamic therapy in doxorubicin-resistant sarcoma by photochemical internalization of gelonin.
Olsen CE; Berg K; Selbo PK; Weyergang A
Free Radic Biol Med; 2013 Dec; 65():1300-1309. PubMed ID: 24076428
[TBL] [Abstract][Full Text] [Related]
23. Hydrocinchonine, cinchonine, and quinidine potentiate paclitaxel-induced cytotoxicity and apoptosis via multidrug resistance reversal in MES-SA/DX5 uterine sarcoma cells.
Lee SY; Rhee YH; Jeong SJ; Lee HJ; Lee HJ; Jung MH; Kim SH; Lee EO; Ahn KS; Ahn KS; Kim SH
Environ Toxicol; 2011 Aug; 26(4):424-31. PubMed ID: 20196146
[TBL] [Abstract][Full Text] [Related]
24. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
25. ANTIPSYCHOTICS REVERSE P-GLYCOPROTEIN-MEDIATED DOXORUBICIN RESISTANCE IN HUMAN UTERINE SARCOMA MES-SA/Dx5 CELLS: A NOVEL APPROACH TO CANCER CHEMOTHERAPY.
Angelini A; Ciofani G; Conti P
J Biol Regul Homeost Agents; 2015; 29(2):357-65. PubMed ID: 26122223
[TBL] [Abstract][Full Text] [Related]
26. PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma.
Lin ST; May EW; Chang JF; Hu RY; Wang LH; Chan HL
Cell Mol Life Sci; 2015 Jun; 72(12):2395-409. PubMed ID: 25596698
[TBL] [Abstract][Full Text] [Related]
27. Doxorubicin selection for MDR1/P-glycoprotein reduces swelling-activated K+ and Cl- currents in MES-SA cells.
Luckie DB; Krouse ME; Law TC; Sikic BI; Wine JJ
Am J Physiol; 1996 Apr; 270(4 Pt 1):C1029-36. PubMed ID: 8928730
[TBL] [Abstract][Full Text] [Related]
28. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
Beketic-Oreskovic L; Durán GE; Chen KG; Dumontet C; Sikic BI
J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202
[TBL] [Abstract][Full Text] [Related]
29. Allopurinol, furosemide and a phytotherapeutic agent (Bazoton uno) reverse P-glycoprotein-mediated doxorubicin resistance in human uterine sarcoma MES-SA/Dx5 cells: a novel therapeutic perspective.
Angelini A; Centurione MA; Di Pietro R; Centurione L
J Biol Regul Homeost Agents; 2019 May-Jun,; 33(3):991-997. PubMed ID: 31162035
[No Abstract] [Full Text] [Related]
30. Modulation of multidrug resistance P-glycoprotein activity by antiemetic compounds in human doxorubicin-resistant sarcoma cells (MES-SA/Dx-5): implications on cancer therapy.
Angelini A; Conti P; Ciofani G; Cuccurullo F; Di Ilio C
J Biol Regul Homeost Agents; 2013; 27(4):1029-37. PubMed ID: 24382184
[TBL] [Abstract][Full Text] [Related]
31. Genistein Suppresses Growth of Human Uterine Sarcoma Cell Lines via Multiple Mechanisms.
Yeh CC; Fan Y; Jiang L; Yang YL; He B; You L; Mann M
Anticancer Res; 2015 Jun; 35(6):3167-73. PubMed ID: 26026076
[TBL] [Abstract][Full Text] [Related]
32. Radioiodinated agents for imaging multidrug resistant tumors.
Kortylewicz ZP; Augustine AM; Nearman J; McGarry J; Baranowska-Kortylewicz J
Med Chem; 2009 Mar; 5(2):171-81. PubMed ID: 19275716
[TBL] [Abstract][Full Text] [Related]
33. A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance.
Bidwell GL; Davis AN; Fokt I; Priebe W; Raucher D
Invest New Drugs; 2007 Aug; 25(4):313-26. PubMed ID: 17483874
[TBL] [Abstract][Full Text] [Related]
34. Effect of structural modifications of anthracyclines on the ability to overcome drug resistance of cancer cells.
Wasowska M; Wietrzyk J; Opolski A; Oszczapowicz J; Oszczapowicz I
Anticancer Res; 2006; 26(3A):2009-12. PubMed ID: 16827137
[TBL] [Abstract][Full Text] [Related]
35. Exposure to 60 Hz magnetic field can affect membrane proteins and membrane potential in human cancer cells.
Hayashi S; Kakikawa M
Electromagn Biol Med; 2021 Oct; 40(4):459-466. PubMed ID: 34396886
[TBL] [Abstract][Full Text] [Related]
36. Clitocine reversal of P-glycoprotein associated multi-drug resistance through down-regulation of transcription factor NF-κB in R-HepG2 cell line.
Sun J; Yeung CA; Co NN; Tsang TY; Yau E; Luo K; Wu P; Wa JC; Fung KP; Kwok TT; Liu F
PLoS One; 2012; 7(8):e40720. PubMed ID: 22927901
[TBL] [Abstract][Full Text] [Related]
37. Reversal by cefoperazone of resistance to etoposide, doxorubicin, and vinblastine in multidrug resistant human sarcoma cells.
Gosland MP; Lum BL; Sikic BI
Cancer Res; 1989 Dec; 49(24 Pt 1):6901-5. PubMed ID: 2582432
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and uptake of fluorescence-labeled Combi-molecules by P-glycoprotein-proficient and -deficient uterine sarcoma cells MES-SA and MES-SA/DX5.
Larroque-Lombard AL; Todorova M; Golabi N; Williams C; Jean-Claude BJ
J Med Chem; 2010 Mar; 53(5):2104-13. PubMed ID: 20151639
[TBL] [Abstract][Full Text] [Related]
39. Effects of photoactivated 5-aminolevulinic acid hexyl ester on MDR1 over-expressing human uterine sarcoma cells.
Chu ES; Yow CM; Shi M; Ho RJ
Toxicol Lett; 2008 Sep; 181(1):7-12. PubMed ID: 18625294
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells.
Shekari F; Sadeghpour H; Javidnia K; Saso L; Nazari F; Firuzi O; Miri R
Eur J Pharmacol; 2015 Jan; 746():233-44. PubMed ID: 25445037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]